Mediastinal (thymic) large B-cell lymphoma: where do we stand?
about
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphomaRecurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.Primary mediastinal lymphoma: diagnosis and treatment options.Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan.EBV-Positive Grey Zone Lymphoma in an HIV Infected Man from Kampala, Uganda: Case Report.The histological classification of diffuse large B-cell lymphomasThe truncate mutation of Notch2 enhances cell proliferation through activating the NF-κB signal pathway in the diffuse large B-cell lymphomas.Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma.Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival.Grey zone lymphomas: lymphomas with intermediate features.Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma.The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classificationNon-Hodgkin lymphoma and GIST: molecular pathways and clinical expressions.Thymic neoplasm: a rare disease with a complex clinical presentationNodal aggressive B-cell lymphomas: a diagnostic approachSOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients.No evidence for the JAK2 (V617F) or JAK2 exon 12 mutations in primary mediastinal large B-cell lymphoma.Primary Mediastinal Large B-cell Lymphoma Exhibiting Endobronchial Involvement.Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies.Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH).Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line.Cardiac, aortic, and esophageal involvement of a large lymphomaExpression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gain.Chemotherapeutic resistance: surviving stressful situations.KIT mutations in primary mediastinal B-cell lymphoma.Double-punching PMBL.Primary mediastinal large B-cell lymphomas treated with dose-intensified CHOP alone or CHOP combined with radiotherapy.Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997-2016.Absence of BRAF and KRAS hotspot mutations in primary mediastinal B-cell lymphoma.
P2860
Q24672476-78BD86B9-3FF6-40BC-9043-85DD9CDE6DB2Q33669371-83AA4A6D-5465-421B-B9F2-6B0B4708A858Q34455499-0B1BF273-CFF4-4500-9745-5C414B16CB22Q34649109-90F7A12F-25DC-41F9-B745-0B31F58B8969Q34949554-2276D920-A408-407B-A249-B612BFD1FA9FQ35218051-0F9D24C6-9717-440F-ABB1-E7FDD7719682Q35331179-58FB2B85-217C-4E09-AFD9-1AE0AE49CCDBQ35763914-994A849A-0BE8-4F68-9092-E665EB489751Q35849831-4FF3C689-BC66-48FA-BF83-93BCB707BA70Q35882774-869B2DC1-FB6B-4282-964C-799089C804EBQ36150374-63D8D1F9-D4D2-4262-B5B0-D2A7CA465EF9Q36280547-B3FBAAE2-BA3C-4EC7-B906-A4B7E8A865F5Q36474669-38915E15-8194-42AE-A53E-CC241496F250Q36753888-B6F40A8D-0BBF-4DF4-9774-A50ED1E70A48Q36763463-A5B7C62B-BBDD-422D-B515-EFF3FE09C085Q36984836-09582312-90B3-4F18-853F-A7AE5368A0EDQ37320600-D26CE34B-80D1-4EFA-896B-9C01E7A8417AQ37478889-81871ECF-9786-4E96-A239-D24650ED9245Q37905667-1AF65FB7-8D77-41F0-92B9-3AA147DA5803Q40087598-3C6CB7A9-E06F-4112-BFE6-8481CB58E4A5Q40463591-DA3E953A-EE27-48C9-8E32-0D83BC2A7140Q41048623-9DB7940F-BC05-468D-A68F-19226C76C434Q41356776-11152E31-0E31-4FF3-A055-A760952AB821Q42851283-DEC490AE-6396-42B2-8733-2CBEEAA97A5BQ42974506-15A4A7FC-160E-4EAC-A9C2-D350902ECB50Q43106087-B0EFFEFA-9CE5-47BE-9817-E4D90137EE47Q46394302-7F774F32-8A27-45F9-9DC8-BDF3B93E7975Q47636060-D839C5FB-F7CD-422C-AD08-2A203EC36422Q54386133-7FADEFE8-6F39-4536-A236-5A72A8085B1C
P2860
Mediastinal (thymic) large B-cell lymphoma: where do we stand?
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mediastinal (thymic) large B-cell lymphoma: where do we stand?
@ast
Mediastinal (thymic) large B-cell lymphoma: where do we stand?
@en
Mediastinal
@nl
type
label
Mediastinal (thymic) large B-cell lymphoma: where do we stand?
@ast
Mediastinal (thymic) large B-cell lymphoma: where do we stand?
@en
Mediastinal
@nl
prefLabel
Mediastinal (thymic) large B-cell lymphoma: where do we stand?
@ast
Mediastinal (thymic) large B-cell lymphoma: where do we stand?
@en
Mediastinal
@nl
P2093
P1433
P1476
Mediastinal (thymic) large B-cell lymphoma: where do we stand?
@en
P2093
Frank Leithäuser
Martin Bentz
Peter Möller
Stefan Joos
Thomas F E Barth
P304
P356
10.1016/S1470-2045(02)00714-3
P577
2002-04-01T00:00:00Z